相关实验视频
Updated: May 11, 2026

08:23
LAD-Ligation: A Murine Model of Myocardial Infarction
Published on: October 14, 2009
44.5K
向Lcn2以抑制心肌细胞铁亡是一种潜在的治疗方法,可以缓解性心肌病
Cheng Jiang1, MingTong Hou2, Shougang Sun1
1Cardiology Department of Lanzhou, University Second Hospital, Lanzhou, China.
Inflammation
|February 3, 2025
概括
利波卡林-2 (Lcn2) 在败血性心肌病中驱动铁亡. 向Lcn2通过减少毒症,炎症和败血症中的氧化应激来保护心脏功能.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 细胞病理学细胞病理学
背景情况:
- 败血性心肌病 (SCM) 是败血症的一个关键并发症,其特征是心脏功能障碍.
- 细胞死亡的调节形式铁亡,越来越被认为是SCM的关键贡献者.
- 识别用于减轻铁亡的分子标对于治疗SCM至关重要.
研究的目的:
- 为了研究铁化在SCM病变发生中的作用.
- 确定可以在败血症期间抑制心肌细胞中铁亡的新型治疗点.
- 评估Lipocalin-2 (Lcn2) 作为SCM治疗标的潜力.
主要方法:
- 综合转录组和蛋白组分析以确定SCM中的关键基因.
- 在小鼠的结和穿孔 (CLP) 模型中诱导败血症.
- 评估心脏功能,铁亡标志物,炎症,活性氧物种 (ROS) 和线粒体损伤.
主要成果:
- 鉴定出Lipocalin-2 (Lcn2) 是一种与SCM进展相关的基因.
- 在败血症小鼠中,Lcn2淘汰赛显著抑制了心肌细胞铁.
- 准Lcn2导致炎症减少,ROS水平降低,线粒体损伤减轻,心脏功能恢复.
结论:
- 在SCM中,Lcn2在促进铁和心脏功能障碍方面发挥着重要作用.
- 针对Lcn2成为SCM的一个有前途的治疗策略.
- 抑制Lcn2可以通过减少铁亡,炎症和线粒体功能障碍来改善心脏损伤.
相关概念视频
Necrosis
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

